Philips shares climb after finalizing pact with U.S. over device sales
By Steve Goldstein
Philips reiterated its financial outlook on Wednesday after finalizing a consent degree with the U.S. Department of Justice and Food and Drug Administration that will prevent it from selling new respiratory care devices in the U.S. but will allow for exports.
The agreement focuses on its U.S. respironics business that is headquartered in Pittsburgh, after it stopped selling Continuous Positive Airway Pressure or Bilevel Positive Airway Pressure sleep therapy devices and other respiratory care devices in 2021 following a recall over the risk that foam would break down and be swallowed.
Philips is still allowed to service devices and sell accessories.
Philips shares (NL:PHIA) (PHG) jumped 4% in early Amsterdam trade. The stock is down 6% this year.
The Food and Drug Administration said the consent decree requires a recall remediation plan providing for either new or remediated devices or refunds. The FDA said Philips will have to receive written notice they're in compliance on current good manufacturing practice, reporting corrections and removals and medical device reporting.
Philips said it still expects "costs of around 100 basis points" this year for remediation activities and profit disgorgement payments, as it reiterated its guidance that calls for mid single digit sales growth and low teens margins excluding those costs.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-10-24 0330ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings, Is Coinbase Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy
-
Energy Transfer Earnings: M&A Drives Guidance Increase In Solid Quarter
-
The Best Healthcare Stocks to Buy
-
Going Into Earnings, Is Home Depot Stock a Buy, a Sell, or Fairly Valued?